Wyden Probes Tax-Exempt Pain Group with Ties to Opioid Makers

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today raised concerns about ties between opioid manufacturers and the tax-exempt American Academy of Pain Medicine (AAPM), an organization that advocates on pain management issues including the use of opioids. “The opioid epidemic is claiming tens of thousands of lives every year,” Wyden said. “As the […]

Wyden Calls for Lower Barriers to Vaccinations

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today urged the Trump administration to take additional steps to help prevent the spread of vaccine-preventable diseases, in light of reports that parts of the country including Oregon have seen outbreaks of these diseases. “Preventing the spread of contagious diseases in our communities requires […]

Wyden, Grassley Demand Answers on CBP List Targeting Journalists

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and Finance Committee Chairman Chuck Grassley, R-Iowa, today requested answers about U.S. Custom and Border Protection (CBP) Agents reportedly targeting journalists for searches, in a letter to Customs Commissioner Kevin McAleenan. Media reports indicate that CBP placed at least seven American journalists covering U.S.-Mexico […]

Wyden Statement at Finance Committee Hearing on Nursing Homes

Generations ago, with Social Security, America closed the door to the era of impoverished seniors living out their last years in almshouses and poor farms. Decades later, with Medicare and Medicaid, it guaranteed that seniors would have access to health care. To continue that hard work, one of the challenges this country faces today is […]

Wyden Statement on Retirement of Taxpayer Advocate Nina Olson

Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) issued the following statement today on Taxpayer Advocate Nina Olson’s announcement that she will retire from her position at the end of July: “With all Nina Olson’s successes at identifying and helping to solve problems taxpayers face under our broken tax system, she deserves a public approval […]

Wyden: Pharma Must Lower List Prices Under Proposed Changes

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today called on the major pharmaceutical manufacturers that testified before the committee earlier this week to pledge their support for federal legislation that would lower list prices if middlemen rebates were significantly diminished. “All the happy talk from drug executives will not amount to […]